List view / Grid view

Anish Suri (Cue Biopharma)

 

article

Translating ‘nature’s cues’ into breakthrough immunotherapies

25 July 2024 | By ,

Discover how Cue Biopharma harnesses the curative potential of the body’s intrinsic immune system to develop treatments for oncology and autoimmune diseases. Here, Anish Suri, Chief Scientific Officer of Cue Biopharma, explains how its platforms and biologics are designed to selectively modulate disease-specific T cells to restore immune balance, aiming…